Jagsonpal Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,061	112.15	127.6	110.53	225.26
Short-Term Investments	-	1,175	1,352	1,036	245.31
Cash & Short-Term Investments	1,061	1,287	1,479	1,146	470.57
Cash Growth	-17.57%	-12.98%	29.06%	143.59%	-24.34%
Accounts Receivable	171.91	131.76	109.51	208.72	155.77
Receivables	171.91	131.76	109.51	208.72	155.77
Inventory	146.43	152	149.97	206.76	297.42
Prepaid Expenses	-	16.62	16.02	10.68	10.62
Other Current Assets	51.35	24.24	212.95	73.17	156.43
Total Current Assets	1,431	1,612	1,968	1,646	1,091
Property, Plant & Equipment	73.5	88.37	93.02	242.78	225.73
Long-Term Investments	-	168.62	47	33.84	290.55
Goodwill	96.93	96.93	-	-	0.3
Other Intangible Assets	682.67	759.24	-	-	-
Other Long-Term Assets	882.78	57.5	62.97	27.25	34.86
Total Assets	3,167	2,783	2,171	1,949	1,642
Accounts Payable	115.81	97.34	75.96	165.8	185.5
Accrued Expenses	-	101.99	74.19	88.86	79.86
Current Portion of Leases	15.76	16.07	13.84	7.54	-
Current Income Taxes Payable	5.57	-	-	0.19	2.33
Current Unearned Revenue	-	9.1	12.94	6.12	-
Other Current Liabilities	145.84	34.54	14.35	7.2	2.03
Total Current Liabilities	282.98	259.04	191.28	275.71	269.72
Long-Term Leases	65.89	76.32	75.57	52.47	-
Long-Term Deferred Tax Liabilities	44.41	30.7	20.73	21.63	32.38
Other Long-Term Liabilities	11.77	17.04	9.18	10.75	12.56
Total Liabilities	405.05	383.1	296.76	360.56	314.66
Common Stock	133.93	132.8	132.19	130.99	130.99
Additional Paid-In Capital	-	140.56	111.2	6	6
Retained Earnings	-	1,906	1,460	1,363	1,112
Comprehensive Income & Other	2,628	219.65	170.7	88.52	78.87
Shareholders' Equity	2,762	2,400	1,874	1,589	1,328
Total Liabilities & Equity	3,167	2,783	2,171	1,949	1,642
Total Debt	81.65	92.39	89.41	60.01	-
Net Cash (Debt)	979.55	1,195	1,390	1,086	470.57
Net Cash Growth	-18.02%	-14.03%	27.96%	130.84%	-15.07%
Net Cash Per Share	14.35	17.75	20.96	16.59	7.18
Filing Date Shares Outstanding	69.34	66.4	66.09	65.5	65.5
Total Common Shares Outstanding	69.34	66.4	66.09	65.5	65.5
Working Capital	1,148	1,353	1,777	1,370	821.09
Book Value Per Share	39.83	36.14	28.35	24.26	20.27
Tangible Book Value	1,982	1,543	1,874	1,589	1,327
Tangible Book Value Per Share	28.59	23.24	28.35	24.26	20.27
Land	-	-	-	87.59	87.59
Buildings	-	-	-	163.8	163.8
Machinery	-	14.77	20.38	18.02	329.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.